Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of EUR 72.07 billion. The enterprise value is 91.41 billion.

Market Cap	72.07B
Enterprise Value	91.41B

Important Dates

The next estimated earnings date is Wednesday, July 16, 2025.

Earnings Date	Jul 16, 2025
Ex-Dividend Date	Jun 10, 2025

Share Statistics

Current Share Class	225.93M
Shares Outstanding	n/a
Shares Change (YoY)	-2.07%
Shares Change (QoQ)	-1.69%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	225.42M

Valuation Ratios

The trailing PE ratio is 13.17 and the forward PE ratio is 10.89.

PE Ratio	13.17
Forward PE	10.89
PS Ratio	0.43
PB Ratio	1.83
P/TBV Ratio	36.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.67, with an EV/FCF ratio of 26.89.

EV / Earnings	16.70
EV / Sales	0.58
EV / EBITDA	10.67
EV / EBIT	11.71
EV / FCF	26.89

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.70.

Current Ratio	1.43
Quick Ratio	1.30
Debt / Equity	0.70
Debt / EBITDA	2.99
Debt / FCF	8.17
Interest Coverage	7.23

Financial Efficiency

Return on equity (ROE) is 14.17% and return on invested capital (ROIC) is 8.17%.

Return on Equity (ROE)	14.17%
Return on Assets (ROA)	4.93%
Return on Invested Capital (ROIC)	8.17%
Return on Capital Employed (ROCE)	11.86%
Revenue Per Employee	1.63M
Profits Per Employee	52,538
Employee Count	104,200
Asset Turnover	1.58
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 1.72 billion in taxes.

Income Tax	1.72B
Effective Tax Rate	23.91%

Stock Price Statistics

The stock price has decreased by -35.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-35.50%
50-Day Moving Average	346.82
200-Day Moving Average	383.65
Relative Strength Index (RSI)	36.39
Average Volume (20 Days)	2

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.42

Income Statement

In the last 12 months, Elevance Health had revenue of EUR 169.43 billion and earned 5.47 billion in profits. Earnings per share was 23.69.

Revenue	169.43B
Gross Profit	46.99B
Operating Income	8.45B
Pretax Income	7.18B
Net Income	5.47B
EBITDA	9.10B
EBIT	8.45B
Earnings Per Share (EPS)	23.69

Full Income Statement

Balance Sheet

The company has 31.13 billion in cash and 27.76 billion in debt, giving a net cash position of -20.82 billion.

Cash & Cash Equivalents	31.13B
Total Debt	27.76B
Net Cash	-20.82B
Net Cash Per Share	n/a
Equity (Book Value)	39.43B
Book Value Per Share	174.28
Working Capital	17.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.48 billion and capital expenditures -1.09 billion, giving a free cash flow of 3.40 billion.

Operating Cash Flow	4.48B
Capital Expenditures	-1.09B
Free Cash Flow	3.40B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.74%, with operating and profit margins of 4.99% and 3.23%.

Gross Margin	27.74%
Operating Margin	4.99%
Pretax Margin	4.24%
Profit Margin	3.23%
EBITDA Margin	5.37%
EBIT Margin	4.99%
FCF Margin	2.01%

Dividends & Yields

This stock pays an annual dividend of 6.10, which amounts to a dividend yield of 1.88%.

Dividend Per Share	6.10
Dividend Yield	1.88%
Dividend Growth (YoY)	6.00%
Years of Dividend Growth	6
Payout Ratio	25.60%
Buyback Yield	2.07%
Shareholder Yield	3.95%
Earnings Yield	7.60%
FCF Yield	4.72%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5